DPP SARS-COV-2 ANTIGEN

Serial Number 90222420
Registration 6654809
700

Registration Progress

Application Filed
Sep 29, 2020
Under Examination
Jun 29, 2021
Approved for Publication
May 4, 2021
Published for Opposition
May 4, 2021
Registered
Feb 22, 2022

Trademark Image

DPP SARS-COV-2 ANTIGEN

Basic Information

Serial Number
90222420
Registration Number
6654809
Filing Date
September 29, 2020
Registration Date
February 22, 2022
Published for Opposition
May 4, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 22, 2022
Registration
Registered
Classes
005

Rights Holder

Chembio Diagnostic Systems Inc.

03
Address
3661 Horseblock Road
Medford, NY 11763

Ownership History

Chembio Diagnostic Systems Inc.

Original Applicant
03
Medford, NY

Chembio Diagnostic Systems Inc.

Owner at Publication
03
Medford, NY

Chembio Diagnostic Systems Inc.

Original Registrant
03
Medford, NY

Legal Representation

Attorney
David S. Jacobson

USPTO Deadlines

Next Deadline
839 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-02-22)
Due Date
February 22, 2028
Grace Period Ends
August 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Mar 9, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 9, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 9, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 9, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 9, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 9, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 21, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 20, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 13, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 12, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 22, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 22, 2021 IUAF S USE AMENDMENT FILED Loading...
Jun 29, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 4, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 4, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 14, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 5, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 5, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 5, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 5, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 2, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 13, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 2, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test strips for use in the field of infectious diseases
First Use Anywhere: Dec 22, 2021
First Use in Commerce: Dec 22, 2021

Additional Information

Pseudo Mark
DPP SARS-COV-TWO ANTIGEN

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"SARS-COV-2 ANTIGEN"